Published in Clin Exp Immunol on September 01, 1973
Immune response to hepatitis B surface antigen. Infect Immun (1975) 1.59
T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection. Gut (1977) 1.42
Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers. Clin Exp Immunol (1985) 1.09
Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis. Gut (1977) 1.08
In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements. J Clin Invest (1984) 0.98
Immunological aspects of chronic active hepatitis. Clin Exp Immunol (1987) 0.94
Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens. Infect Immun (1984) 0.93
Acute hepatitis: significance of changes in complement components. Clin Exp Immunol (1977) 0.92
Studies on immunoregulatory mechanisms in acute and chronic hepatitis B. Clin Exp Immunol (1983) 0.91
Delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) in patients with type B acute and chronic hepatitis. Clin Exp Immunol (1985) 0.81
Influence of (+)-cyanidanol-3 on the leukocyte migration inhibition test carried out in the presence of purified protein derivative and hepatitis B surface antigen. Infect Immun (1981) 0.79
Cell-mediated immunity to hepatitis B virus antigens in mice: correlation of in vivo and in vitro assays. Clin Exp Immunol (1986) 0.79
Hepatitis B core antigen immune complexes in the liver of hepatitis B patients. Clin Exp Immunol (1979) 0.78
ad and ay subtypes of hepatitis B antigen in a case of hypogammaglobulinaemia. J Clin Pathol (1975) 0.75
Human lymphocyte migration as a parameter of hypersensitivity. Acta Med Scand (1967) 7.97
An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A (1968) 7.33
Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet (1972) 5.17
Immune complexes in hepatitis. Lancet (1969) 4.33
An in vitro assay for cellular hypersensitivity in man. J Immunol (1970) 3.73
Cell migration inhibition factor released by antigen from human peripheral lymphocytes. Nature (1968) 3.62
An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response. N Engl J Med (1969) 3.54
Australia antigen in acute and chronic liver disease. Lancet (1969) 2.65
Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet (1970) 2.60
Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma. Lancet (1970) 2.11
A study of Australia-antigen-positive blood donors and their recipients, with special reference to liver histology. N Engl J Med (1972) 1.85
Lymphocyte transformation by Australia antigen. Lancet (1971) 1.71
Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. N Engl J Med (1971) 1.60
Australia antigen and hepatitis. Studies in asymptomatic people and lepromatous leprosy patient. Arch Intern Med (1970) 1.20
Liver disease in Australia-antigen-positive blood-donors. Lancet (1971) 1.14
Relation between Australia antigen and autoimmune hepatitis. Lancet (1972) 1.11
Antibody to hepatitis-associated antigen. Frequency and pattern of response as detected by radioimmunoprecipitation. JAMA (1972) 1.07
Hepatitis-associated antigen and antibody in Uganda: correlation of serological testing with histopathology. Br Med J (1972) 1.04
Liver biopsies in patients with and without Australia antigen. Arch Pathol (1972) 0.87
Fabrication of microfluidic systems in poly(dimethylsiloxane). Electrophoresis (2000) 9.45
Analysis of survival by tumor response. J Clin Oncol (1983) 5.91
Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol (2001) 5.46
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med (1992) 5.42
The will and the ways: development and validation of an individual-differences measure of hope. J Pers Soc Psychol (1991) 4.55
Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans. J Virol (1986) 3.36
Laparoscopic versus minilaparotomy cholecystectomy: a randomised trial. Lancet (1994) 3.29
Late mortality after surgery for peptic ulcer. N Engl J Med (1982) 2.73
Examination of cardiorespiratory changes during upper gastrointestinal endoscopy. Comparison of monitoring of arterial oxygen saturation, arterial pressure and the electrocardiogram. Anaesthesia (1991) 2.52
The western black-legged tick, Ixodes pacificus: a vector of Borrelia burgdorferi. Am J Trop Med Hyg (1985) 2.50
The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis (2001) 2.47
Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study. Ann Rheum Dis (1967) 2.43
Increasing physician productivity and the hospitalization characteristics of practices using Medex. A progress report. Northwest Med (1971) 2.34
The role of prefrontal cortex and posterior parietal cortex in task switching. Proc Natl Acad Sci U S A (2000) 2.28
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol (2002) 2.28
The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols. Sarcoma (2001) 2.10
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol (2001) 2.06
Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet (1986) 2.05
Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet (1999) 2.04
Generation and characterization of a delta F508 cystic fibrosis mouse model. Nat Genet (1995) 1.96
Arterial oxygen saturation during upper gastrointestinal endoscopy: the effects of a midazolam/pethidine combination. Gut (1990) 1.93
Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J (1998) 1.83
Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med (1983) 1.82
Production of a severe cystic fibrosis mutation in mice by gene targeting. Nat Genet (1993) 1.80
Central venous catheterisation. Ann R Coll Surg Engl (1980) 1.78
Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br J Surg (1996) 1.78
Exponential survival trees. Stat Med (1989) 1.75
Gastric studies in sjögren's syndrome. Gut (1966) 1.73
Lymphocyte transformation by Australia antigen. Lancet (1971) 1.71
Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol (1999) 1.70
Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol (1993) 1.69
Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group. Cancer (1997) 1.67
Acute caecal volvulus. Br J Surg (1980) 1.63
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol (1993) 1.58
New approach to rhinoplasty. A five-year reappraisal. Arch Otolaryngol (1971) 1.58
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol (2000) 1.56
Waterhouse-Friderichsen syndrome caused by a DF-2 bacterium in a splenectomised patient. J Clin Pathol (1981) 1.56
Secretor status, smoking and carriage of Neisseria meningitidis. Epidemiol Infect (1990) 1.55
Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991. J Clin Oncol (1997) 1.54
Immunological features of idiopathic Addison's disease: an antibody to cells producing steroid hormones. Clin Exp Immunol (1968) 1.53
Volvulus of the small intestine in adults. World J Surg (1986) 1.51
Is more better? Dose intensity in neuroblastoma. J Clin Oncol (1991) 1.51
Studies on pregnancy-associated globulin. Clin Exp Immunol (1973) 1.50
Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol (1999) 1.48
Randomized, prospective study of nail bed ablation for recurrent ingrowing toenails. J R Coll Surg Edinb (1990) 1.46
Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol (1994) 1.45
Symptomatic outcome 1 year after laparoscopic and minilaparotomy cholecystectomy: a randomized trial. Br J Surg (1995) 1.44
Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol (1999) 1.44
Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J Pediatr Surg (2000) 1.43
Randomized placebo-controlled trial of local anaesthetic infusion in day-case inguinal hernia repair. Br J Surg (1998) 1.42
Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide. J Clin Oncol (2004) 1.41
Entangled macroscopic quantum States in two superconducting qubits. Science (2003) 1.41
Laparoscopic and minilaparotomy cholecystectomy: a randomized trial comparing postoperative pain and pulmonary function. Surgery (1994) 1.38
Guidelines on the performance of chemical pathology assays outside the laboratory. Br Med J (Clin Res Ed) (1981) 1.37
Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood (1992) 1.36
Quantum logic gates for coupled superconducting phase qubits. Phys Rev Lett (2003) 1.33
Radiation-induced intracranial neoplasms. A report of three possible cases. Cancer (1984) 1.32
Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut (1993) 1.31
Hydrofluoric acid burns of the hand: mechanism of injury and treatment. J Hand Surg Am (1988) 1.28
Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis. Neuropathol Appl Neurobiol (2001) 1.28
A reasoned approach to nasal base surgery. Arch Otolaryngol (1984) 1.27
Ectopic adrenal tissue in adults. Postgrad Med J (1980) 1.25
The frequency of gastrointestinal endocrine tumours in a well-defined population--Northern Ireland 1970-1985. Q J Med (1989) 1.25
Chemistry of individual aerosol particles from Chandler, Arizona, an arid urban environment. Environ Sci Technol (1988) 1.25
Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report. Leukemia (2012) 1.25
Surgery and salmonella. BMJ (1990) 1.25
Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT). J Nucl Med (1982) 1.24
Individual particle types in the aerosol of phoenix, Arizona. Environ Sci Technol (1995) 1.24
Salmonella enteritidis phage type 4 infection of broiler chickens: a hazard to public health. Lancet (1989) 1.24
Reproducibility of BOLD-based functional MRI obtained at 4 T. Hum Brain Mapp (1999) 1.22
The distribution of herpes simplex type 1 antigen in mouse central nervous system after different routes of inoculation. J Neurol Sci (1983) 1.22
A study of the influence of cyanuric acid on the bactericidal effectiveness of chlorine. Am J Public Health Nations Health (1965) 1.22
Preliminary studies on the anti-inflammatory and analgesic activity of the methanolic fraction of the root extract of Tragia involucrata Linn. J Ethnopharmacol (2000) 1.22
Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet (1993) 1.21
Association of Thyrotoxicosis and Auto-immune Thyroiditis. Br Med J (1961) 1.20
Immunological features of idiopathic Addison's disease: characterization of the adrenocortical antigens. Clin Exp Immunol (1968) 1.19
Lymphocytes with T and B cell properties in a lymphoproliferative disorder. Lancet (1974) 1.18
Distribution of certain autoantibodies in monozygotic and dizygotic twins. Ann Rheum Dis (1966) 1.17
Malignancy in a vestibular schwannoma. Report of a case with central neurofibromatosis, treated by both stereotactic radiosurgery and surgical excision, with a review of the literature. Br J Neurosurg (2002) 1.17
Evidence for a role of hepatitis virus B in chronic alcoholic liver disease. Lancet (1972) 1.16
p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood (1996) 1.16
Human lymphocyte sub-populations and K cells. Int Arch Allergy Appl Immunol (1976) 1.15
Plurality and resemblance in fMRI data analysis. Neuroimage (1999) 1.15
Letter: Auto-rosette formation by human thymocytes and lymphocytes. Lancet (1974) 1.14
Acute pancreatitis and non-Hodgkin's lymphoma. Postgrad Med J (1987) 1.14
Frequency of autoantibodies in patients with chromatin-positive Klinefelter's syndrome and their parents. Lancet (1966) 1.13
Effect of levodopa on urinary bladder. Urology (1976) 1.13
Carbodiimide modification of superhelical PM2 DNA: considerations regarding reaction at unpaired bases and the unwinding of superhelical DNA with chemical probes. Nucleic Acids Res (1977) 1.13
Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow. J Natl Cancer Inst (1993) 1.12
Graphical analysis of MR feature space for measurement of CSF, gray-matter, and white-matter volumes. J Comput Assist Tomogr (1993) 1.12
What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer (2001) 1.11
Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials. Cancer Treat Rep (1985) 1.11
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol (1994) 1.10
The surgical treatment of ingrowing toenails. J Bone Joint Surg Br (1991) 1.10
Regulatory role of parasites: impact on host population shifts with resource availability. Science (1991) 1.10
Purification and properties of peroxidase from Nitrosomonas europaea. J Bacteriol (1968) 1.09
Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med (1996) 1.09
Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). J Pediatr Surg (2000) 1.08
Clinical spectrum of "solitary ulcer" of the rectum. Gastroenterology (1983) 1.08
Routine sampling of air for fungi does not predict risk of invasive aspergillosis in immunocompromised patients. J Hosp Infect (2008) 1.08